Skip to content

CORRI LA VITA
SELECTS NEW PROJECTS THROUGH A PUBLIC CALL

Prevention, treatment, and quality of life are at the heart of the 2026 call for proposals promoted by the CORRI LA VITA Onlus Association, which once again this year supports initiatives for women with breast cancer.

The call is open to public and private non-profit organizations based in Italy. They may submit projects with a maximum duration of 12 months by June 15, 2026, via certified email (PEC).

Funding of up to €100,000 is available for single-institution initiatives, and up to €200,000 for multidisciplinary programs or for the purchase of medical equipment.

Particular attention will be given to projects with a strong focus on care, especially those aimed at prevention, diagnosis, and treatment pathways—from promoting healthy lifestyles and participation in mammography screening programs, to improving access to diagnostic services, enhancing treatment options, and providing psychological and rehabilitative support.

Proposals will be evaluated by the Scientific Committee and the Board of Directors of the CORRI LA VITA Onlus Association. Priority will be given to projects that demonstrate integration between local expertise and facilities, adopt a multidisciplinary approach, and include elements of innovation and sustainability, with measurable outcomes capable of addressing the real needs of women—particularly in more vulnerable contexts.

The final ranking will be published by December 15, 2026, on this website.

The Board of Directors includes long-standing members and representatives of the CORRI LA VITA Onlus Association, including President Eleonora Frescobaldi, Honorary President Bona Frescobaldi, Vice President Laura Bartoli, along with Marco Bernini, Andrea Catellacci, Lamberto Frescobaldi, Marzio Parri, Diego Paternò Castello di San Giuliano, Cecilia Ristori, and Carlo Speranzini.

The Scientific Committee is composed of highly experienced professionals: Professor Laura Biganzoli (Oncologist), Dr. Elisabetta Coccia (Gynecologist), Dr. Paola Mantellini (Epidemiologist), and Professor Marco Bernini (Oncologic Surgeon). Their contribution ensures that the funds raised are used effectively, transparently, and on a solid scientific basis.